Big Pharma Fined $3.75 Billion in Fraud Penalties in Fiscal 2013

According to the U.S. Departments of Justice and Health and Human Services, these departments recovered $4.3 billion in criminal and civil fines in the 2013 fiscal year, which ended in September 2013.  This is a $100 million increase from the 2012 fiscal year.  The five-year total in fines has now reached $19.2 billion.  Pharma drugmakers [...]

March 3rd, 2014|Drug and Medical Device Litigation|Comments Off on Big Pharma Fined $3.75 Billion in Fraud Penalties in Fiscal 2013

Whistleblowers, Undercover Employees Wearing Wires Led To Johnson & Johnson’s Guilty Plea Involving Risperdal

As reported earlier, Johnson & Johnson will pay $2.2 billion due to its practices of improper marketing and failure to warn.  Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, admitted that it promoted Risperdal to health care providers for treatment of psychotic symptoms and associated behavioral disturbances exhibited by elderly, non-schizophrenic dementia patients. More facts [...]

November 12th, 2013|Drug and Medical Device Litigation|Comments Off on Whistleblowers, Undercover Employees Wearing Wires Led To Johnson & Johnson’s Guilty Plea Involving Risperdal